semaglutide bmi 27 NICE recommends semaglutide for obesity treatment Semaglutide 2.4 mg Clinical Outcomes

PlexusDx serves all 50 states and accepts HSA and FSA funds for additional tax advantages

Available from: Filippatos TD, Panagiotopoulou TV, Elisaf MS

Interviewed by LaGanzie Kale recently on Community Conversations on KLEK-FM, Speights offered a physicians perspective on the fast-growing class of drugs, including semaglutide-based medications commonly marketed under brand names such as Ozempic and Wegovy

The primary outcome measures included papilledema (ICD-10 code H47.1), headache manifestations (ICD-10 codes G44.-), and visual disturbances or blindness (ICD-10 codes H53.- and H54.-)

If palpitations last more than 10 minutes, feel chaotic or irregular, or occur with syncope or chest pressure, contact your prescriber immediately for ECG evaluation and lab work including potassium, magnesium, and thyroid function